Stock Information
Natera Inc (NTRA)
Ticker Symbol: NTRA
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $28,704.25 mil
Piotroski score: 6
PE Ratio: N/A
EPS (TTM): -1.5333
Revenue (TTM): $16.67 M
Dividend Yield: N/A%
ROE: -15.28%
Latest News
-
Natera Positioned To Capture Growing $20 Billion MRD Opportunity-Analyst
Tue, Apr 14, 2026 2:30 PM
-
William Blair Initiates Coverage On Natera with Outperform Rating
Tue, Apr 14, 2026 9:55 AM
-
Allogene Therapeutics Stock Hits 52-Week High - Here's Why
Mon, Apr 13, 2026 12:59 PM
-
Natera shares are trading higher amid sympathy with Allogene Therapeutics, which used the company's technology in its Phase 2 lymphoma trial.
Mon, Apr 13, 2026 10:15 AM
-
Natera Highlights Positive Interim Futility Analysis from Allogene Therapeutics’ MRD-Guided ALPHA3 Trial in Large B-Cell Lymphoma
Mon, Apr 13, 2026 8:05 AM
Key Financials
Financial data not available
